The Naturalyte dialysis liquid acid concentrate is a product used in the treatment of acute and chronic renal failure during hemodialysis. Naturalyte concentrate is created for usage along with a three-stream hemodialysis mechanism that has been calibrated for acid and bicarbonate concentrates.
The compounds within are used as a dialysate composition. These compounds are used in assisting the body in removing toxins from the kidneys in dialysis and more specifically, during hemodialysis. During the process of hemodialysis, patients try to get all the creatine, urea, potassium, and free water out of the kidneys that are no longer able to be processed.
Because the process of hemodialysis is meant to utilize ultrafiltration in the semipermeable membrane, it is required to put some of the more important aspects back into the blood. One important component that has to be replaced is a sodium bicarbonate that helps fix the proper blood acidity in the process.
The makers of Naturalyte dialysis Liquid Acid Concentrate are Fresenius Medical Care, which is the largest dialysis company in the entire nation. It is believed that Fresenius has failed to properly warn doctors and patients of the severe risks associated with proper dosing of Naturalyte Liquid Acid Concentrate. Sadly, many of the compounds of Fresenius have had dosing errors which have resulted in severe Naturalyte side effects. If you or a loved one has suffered from severe Naturalyte complications, you may be entitled to financial compensation from the makers of the compound through a Naturalyte dialysis lawsuit.
The United States Food and Drug Administration (FDA) recently issued a Class I recall for their product Naturalyte Liquid Acid due to its potentially hazardous side effects. The recall affects more than 400,000 patients currently undergoing dialysis.
08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8, 08-3201-4, 08-3231-1, 08-3251-9, 08-3301-2, 08-4123-1, 08-4223-7, 08-4225-1, 08-4230- 2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1, 13-3251-9, 13-4123-1, 13-4220-1, 13-4225-1, 13-4325-1
Fresenius is currently under investigation by the FDA to see whether the company violated federal regulations by not alerting all customers of GranuFlo & NaturaLyte of the health risks. The FDA issued a Class 1 recall of GranuFlo & NaturaLyte from all clinics on June 27, 2012.
If you or a loved one has experienced cardiac arrest, heart attack, stroke following dialysis with GranuFlo or Naturalyte, please contact the Willis Law Firm for a free consultation for a potential GranuFlo dialysis lawsuit. You may be entitled to financial compensation from the makers of Naturalyte in a Naturalyte dialysis lawsuit.